Sampatrilat

CAS : 129981-36-8

Ref. TM-T16840

Informations sur le produit

• Nom: Sampatrilat
• Synonymes: UK-81252, beta-Alanine, 2-((1-(((1-carboxy-2-(4-hydroxyphenyl)ethyl)amino)carbonyl)cyclopentyl)methyl)-N-(N2-(methylsulfonyl)-L-lysyl)-, (S-(R*,R*))-, N-({1-[(2R)-3-carboxy-2-{[N~2~-(methylsulfonyl)-L-lysyl]amino}propyl]cyclopentyl}carbonyl)-L-tyrosine, L-Tyrosine, N2-(methylsulfonyl)-L-lysyl-1-[(2S)-3-amino-2-carboxypropyl]cyclopentanecarbonyl-, N-(1-(2-Carboxy-3-(N(2)-mesyllysylamino)propyl)-1-cyclopentylcarbonyl)tyrosine, (S-(R*,R*))-2-((1-(((1-Carboxy-2-(4-hydroxyphenyl)ethyl)amino)carbonyl)cyclopentyl)methyl)-N-(N2-(methylsulfonyl)-L-lysyl)-beta-Alanine, UK 81252, β-Alanine, 2-[[1-[[[1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]carbonyl]cyclopentyl]methyl]-N-[N2-(methylsulfonyl)-L-lysyl]-, [S-(R*,R*)]-, N2-(Methylsulfonyl)-L-lysyl-1-[(2S)-3-amino-2-carboxypropyl]cyclopentanecarbonyl-L-tyrosine, N-((1-((S)-3-((S)-6-Amino-2-methanesulfonamidohexanamido)-2-carboxypropyl)cyclopentyl)carbonyl)-L-tyrosine, UK 81,252

Description

Sampatrilat, an oral vasopeptidase inhibitor, more potently blocks C-domain ACE (Ki=13.8 nM) over N-domain (Ki=171.9 nM).

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 584.68
• Formule: C₂₆H₄₀N₄O₉S
• Degré de pureté: 98%
• Couleur/Forme: Solid